MedPath

Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon

Not Applicable
Completed
Conditions
Hepatic Flexure Colon Cancer
Proximal Transverse Colon Cancer
Interventions
Procedure: laparoscopic ileocecus-sparing right hemicolectomy
Registration Number
NCT04479111
Lead Sponsor
Zhejiang University
Brief Summary

To investigate whether laparoscopic ileocecus-sparing right hemicolectomy is feasible and oncologically safe

Detailed Description

Our study is a single arm, single center clinical trial. The enrolled patients will accept laparoscopic ileocecus-sparing right hemicolectomy. The primary endpoint: postoperative complications, 1-year local recurrence. The second endpoint: conversion to conventional right hemicolectomy, time to first flatus after surgery, number of harvested lymph nodes, 3-year disease free survival, R0 resection, Specimen morphometry

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patients suitable for curative surgery 18-75years old
  2. ASA grade I-III
  3. Qualitative diagnosis: a pathological diagnosis of adenocarcinoma;
  4. Localization diagnosis: the tumor located at hepatic flexure and proximal transverse colon(proximal to the right branch of middle colic artery);
  5. Enhanced CT scan of chest, abdominal and pelvic cavity: assessment of tumor stage is T1-T4N0 or TanyN+; there is no distant metastasis.
  6. Intraoperative measurement: the distance between colic branch of ileocolic artery and proximal edge of the tumor should be longer than 5cm.
  7. Informed consent
Exclusion Criteria
  1. Simultaneous or metachronous multiple primary colorectal cancer;
  2. History of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.
  3. Preoperative imaging examination results show: fused lymph node at the root of ileocolic artery.
  4. Distant metastasis.
  5. History of any other malignant tumor in recent 5 years.
  6. Patients need emergency operation.
  7. Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc).
  8. Informed consent refusal

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
LISRH grouplaparoscopic ileocecus-sparing right hemicolectomyFollowing the principle of complete mesocolic excision(CME), Ileocecus-Sparing Right colectomy refers to the resection of the most portion of the ascending colon, hepatic flexure and mid to distal transverse colon. The extent of lymph node dissection and length of distal resection margin are similar to conventional right hemicolectomy. The length of proximal resection margin varies.
Primary Outcome Measures
NameTimeMethod
1-year local recurrence7 days after surgery

rate of local recurrence one year after surgery, including anastomotic recurrence, recurrence around ileocolic vessels and surgical trunk of superior mesenteric vein,

Postoperative complicationsup to 90 days after surgery

Postoperative complications used to calculate the Comprehensive Complication Index (CCI) will be recorded

Secondary Outcome Measures
NameTimeMethod
R0 resectionup to 1 week after surgery

Rate of resection without any affected margins during the surgical procedure according to the pathological report

Specimen morphometrywithin 30 days

The gross dimensions of resected specimen: length, the distal and proximal resection margins distance, vascular pedicle length

3-year disease free survival3 years

the time from enrollment until disease relapse or death from any cause 3 years after surgery

Conversion to conventional right hemicolectomy1 day of surgery

the rate of conversion to conventional right hemicolectomy

Time to first flatus after surgeryup to 7 days after surgery

days from a colectomy procedure to first occurrence of flatus during subject's postoperative recovery

Number of harvested lymph nodesup to 1 week after surgery

Number of harvested Lymph nodes according to the pathological report

Trial Locations

Locations (1)

The Second Affiliated Hospital of Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath